A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation

The scarcity of age-appropriate pharmaceutical formulations is one of the major challenges impeding successful management of tuberculosis (TB) prevalence in minors. To this end, we designed and assessed the quality of a multiparticulate reconstitutable suspension powder containing fixed dose rifampi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rampedi, Penelope N., Ogunrombi, Modupe O., Wesley-Smith, James, Adeleke, Oluwatoyin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861895/
https://www.ncbi.nlm.nih.gov/pubmed/36678693
http://dx.doi.org/10.3390/pharmaceutics15010064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861895/
https://www.ncbi.nlm.nih.gov/pubmed/36678693
http://dx.doi.org/10.3390/pharmaceutics15010064

Ejemplares similares